Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™ AUDUBON, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that the Excelsius GPS™, a revolutionary robotic guidance and navigation READ MORE

AUDUBON, PA, May 3, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. READ MORE

CONCORD Plus™   We are pleased to announce the launch of our new high viscosity bone cement, CONCORD-Plus™ and accompanying Cement Mixer and Transfer Pack. The CONCORD-Plus™ Bone Cement is ready to inject 3 minutes after mixing and has a 12 minute working time. Compared to READ MORE

ViaCell™ A Cohesive Cellular Allograft with Viable Cells ViaCell™ is a cellular allograft containing viable cells including mesenchymal stem cells and osteoprogenitor cells, which are essential requirements for bone formation. The components of ViaCell™ provide the three essenti READ MORE

Rod Link Reducer   QUARTEX™ The QUARTEX™ Occipito-Cervico-Thoracic (OCT) Stabilization System offers a variety of solutions to the challenges associated with posterior OCT fusion to aid in easier construct assembly. With a comprehensive range of instruments, including threaded dr READ MORE

AUDUBON, PA, May 3, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. READ MORE

Globus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call AUDUBON, Pa., Feb. 07, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth qua READ MORE

Globus Medical Announces CE Mark for Excelsius GPS™ Excelsius GPS™ – Robotic Trajectory Guidance and Navigation for Surgery AUDUBON, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that the E READ MORE

Globus Medical Reports Third Quarter 2016 Results AUDUBON, PA, November 8, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016. Worldwide sales decreased 1.0% as re READ MORE

Globus Medical Launches QUARTEX™ OCT Stabilization System QUARTEX™ Occipito-Cervico-Thoracic (OCT) Stabilization System is a threaded screw and rod platform offering true thoracic pedicle screws with diameters up to 5.5 mm, allowing surgeons to take full advantage of varying spinal an READ MORE